TNDM
$67.23
Tandem Diabetes Care
$5.88
9.58%
TNDM
Earnings Whisper ®
N/A
1st Quarter March 2020
Consensus:  ($0.17)
Revenue:  $86.88 Mil
Thursday
Apr 30
4:05 PM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when TNDM reports earnings?
Beat
Meet
Miss

Where is TNDM's stock price going from here?
Up
Flat
Down
Stock chart of TNDM
Analysts
Summary of analysts' recommendations for TNDM
Score
Grade
Pivots
Resistance
$72.57
$70.24
$68.73

$66.40

Support
$64.89
$62.56
$61.05
Tweet
Growth
Description
Tandem Diabetes Care, Inc. is a medical device company. The Company designs, develops, and commercializes products for people with insulin-dependent diabetes. Its products include t:slim Insulin Delivery System. Tandem Diabetes Care, Inc. is headquartered in San Diego, California.
Peers
StrykerBoston ScientificBecton, DickinsonBaxter InternationalAbbott LaboratoriesWatersTeleflexIntegra LifeSciences Holdings3MAbiomed